UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Global cardiovascular and renal outcomes of reduced GFR

Journal of the American Society of Nephrology, 2017-07, Vol.28 (7), p.2167-2179

2017

Volltextzugriff (PDF)

Kidney Function Influences Warfarin Responsiveness and Hemorrhagic Complications

Journal of the American Society of Nephrology, 2009-04, Vol.20 (4), p.912-921

2009

Volltextzugriff (PDF)

A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease

Journal of the American Society of Nephrology, 2021-12, Vol.32 (12), p.2994-3015

2021

Volltextzugriff (PDF)

Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment

Journal of the American Society of Nephrology, 2017-04, Vol.28 (4), p.1023-1039

2017

Volltextzugriff (PDF)

The Effects of High-Protein Diets on Kidney Health and Longevity

Journal of the American Society of Nephrology, 2020-08, Vol.31 (8), p.1667-1679

2020

Volltextzugriff (PDF)

Endothelin antagonist as add-on treatment for proteinuria in diabetic nephropathy: is there light at the end of the tunnel?

Journal of the American Society of Nephrology, 2011-04, Vol.22 (4), p.593-595

2011

Volltextzugriff (PDF)

Trials and tribulations of new agents, novel biomarkers, and retarding renal progression

Journal of the American Society of Nephrology, 2011-06, Vol.22 (6), p.992-993

2011

Volltextzugriff (PDF)

Modifiable Lifestyle Factors for Primary Prevention of CKD: A Systematic Review and Meta-Analysis

Journal of the American Society of Nephrology, 2021-01, Vol.32 (1), p.239-253

2021

Volltextzugriff (PDF)

GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials

Journal of the American Society of Nephrology, 2019-09, Vol.30 (9), p.1735-1745

2019

Volltextzugriff (PDF)

Validity and Utility of a Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression: A Review

Journal of the American Society of Nephrology, 2023-12, Vol.34 (12), p.1928-1935

2023

Volltextzugriff (PDF)

Evaluating Glomerular Filtration Rate Slope as a Surrogate End Point for ESKD in Clinical Trials: An Individual Participant Meta-Analysis of Observational Data

Journal of the American Society of Nephrology, 2019-09, Vol.30 (9), p.1746-1755

2019

Volltextzugriff (PDF)

Glomerular filtration barrier and molecular segregation: guilty as charged?

Journal of the American Society of Nephrology, 2010-12, Vol.21 (12), p.2009-2011

2010

Volltextzugriff (PDF)

Accuracy of GFR Estimating Equations in Patients with Discordances between Creatinine and Cystatin C-Based Estimations

Journal of the American Society of Nephrology, 2023-07, Vol.34 (7), p.1241-1251

2023

Volltextzugriff (PDF)

REIN on obesity, proteinuria and CKD

Journal of the American Society of Nephrology, 2011-06, Vol.22 (6), p.990-992

Choi, Mary E

2011

Volltextzugriff (PDF)

Maturation of GFR in Term-Born Neonates: An Individual Participant Data Meta-Analysis

Journal of the American Society of Nephrology, 2022-07, Vol.33 (7), p.1277-1292

2022

Volltextzugriff (PDF)

Race and the Estimation of GFR: Getting it Right

Journal of the American Society of Nephrology, 2021-06, Vol.32 (6), p.1269-1270

2021

Volltextzugriff (PDF)

Striking a Balance in Simultaneous Heart Kidney Transplant: Optimizing Outcomes for All Wait-Listed Patients

Journal of the American Society of Nephrology, 2020-08, Vol.31 (8), p.1661-1664

2020

Volltextzugriff (PDF)

Reassessing the Inclusion of Race in Diagnosing Kidney Diseases: An Interim Report from the NKF-ASN Task Force

Journal of the American Society of Nephrology, 2021-06, Vol.32 (6), p.1305-1317

2021

Volltextzugriff (PDF)

Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression

Journal of the American Society of Nephrology, 2023-12, Vol.34 (12), p.2025-2038

2023

Volltextzugriff (PDF)

Individualized Risk of CKD Progression among US Adults

Journal of the American Society of Nephrology, 2024-08, Vol.35 (8), p.1076-1083

2024

Volltextzugriff (PDF)

Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy: A Post Hoc Analysis from the SONAR Trial

Journal of the American Society of Nephrology, 2021-11, Vol.32 (11), p.2731-2734

2021

Volltextzugriff (PDF)

Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with CKD

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11), p.2094-2107

2022

Volltextzugriff (PDF)

Measured GFR as a Confirmatory Test for Estimated GFR

Journal of the American Society of Nephrology, 2009-11, Vol.20 (11), p.2305-2313

2009

Volltextzugriff (PDF)

Does Our Classification System for CKD Serve the US Population Well?

Journal of the American Society of Nephrology, 2024-08, Vol.35 (8), p.992-994

2024

Volltextzugriff (PDF)

Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical Simulation

Journal of the American Society of Nephrology, 2019-09, Vol.30 (9), p.1756-1769

2019

Volltextzugriff (PDF)

1 – 25 von 238

Suche als RSS-Feed

Aktive Filter

ThemaMale

Zeitschrift / SerieJournal Of The American Society Of Nephrology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(238)
Mit Volltextzugriff
(232)

Publikationsform

Artikel
(238)

Sprache

Englisch
(238)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(224)
Science & Technology
(224)
Urology & Nephrology
(224)
Humans
(183)
Glomerular Filtration Rate
(179)
Animals
(87)
Biological And Medical Sciences
(71)
Medical Sciences
(64)
Nephrology. Urinary Tract Diseases
(55)
Mice
(33)
Glomerular Filtration Rate - Physiology
(32)
Adult
(31)
Glomerular Filtration Rate - Drug Effects
(30)
Disease Progression
(27)
Female
(25)
Risk Factors
(25)
Creatinine - Blood
(24)
Kidney - Physiopathology
(24)
Rats
(24)
Time Factors
(24)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Zeitschrift / Serie

Clinical Journal Of The American Society Of Nephrology
(1)

Menü

Weitere Dienste

Einstellungen

Global cardiovascular and renal outcomes of reduced GFR

Kidney Function Influences Warfarin Responsiveness and Hemorrhagic Complications

A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease

Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment

The Effects of High-Protein Diets on Kidney Health and Longevity

Endothelin antagonist as add-on treatment for proteinuria in diabetic nephropathy: is there light at the end of the tunnel?

Trials and tribulations of new agents, novel biomarkers, and retarding renal progression

Modifiable Lifestyle Factors for Primary Prevention of CKD: A Systematic Review and Meta-Analysis

GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials

Validity and Utility of a Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression: A Review

Evaluating Glomerular Filtration Rate Slope as a Surrogate End Point for ESKD in Clinical Trials: An Individual Participant Meta-Analysis of Observational Data

Glomerular filtration barrier and molecular segregation: guilty as charged?

Accuracy of GFR Estimating Equations in Patients with Discordances between Creatinine and Cystatin C-Based Estimations

REIN on obesity, proteinuria and CKD

Maturation of GFR in Term-Born Neonates: An Individual Participant Data Meta-Analysis

Race and the Estimation of GFR: Getting it Right

Striking a Balance in Simultaneous Heart Kidney Transplant: Optimizing Outcomes for All Wait-Listed Patients

Reassessing the Inclusion of Race in Diagnosing Kidney Diseases: An Interim Report from the NKF-ASN Task Force

Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression

Individualized Risk of CKD Progression among US Adults

Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy: A Post Hoc Analysis from the SONAR Trial

Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with CKD

Measured GFR as a Confirmatory Test for Estimated GFR

Does Our Classification System for CKD Serve the US Population Well?

Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical Simulation

Aktive Filter

Suchergebnisse filtern